Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback